SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-004351
Filing Date
2020-12-17
Accepted
2020-12-17 17:09:48
Documents
56
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q organicell_10q-043020.htm 10-Q 520126
2 CERTIFICATION organicell_ex3101.htm EX-31.1 7897
3 CERTIFICATION organicell_ex3102.htm EX-31.2 8116
4 CERTIFICATION organicell_ex3201.htm EX-32.1 3216
5 CERTIFICATION organicell_ex3202.htm EX-32.2 3293
  Complete submission text file 0001683168-20-004351.txt   2840531

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bpsr-20200430.xml EX-101.INS 457854
7 XBRL SCHEMA FILE bpsr-20200430.xsd EX-101.SCH 34524
8 XBRL CALCULATION FILE bpsr-20200430_cal.xml EX-101.CAL 39333
9 XBRL DEFINITION FILE bpsr-20200430_def.xml EX-101.DEF 108493
10 XBRL LABEL FILE bpsr-20200430_lab.xml EX-101.LAB 221254
11 XBRL PRESENTATION FILE bpsr-20200430_pre.xml EX-101.PRE 178054
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 201396989
SIC: 3790 Miscellaneous Transportation Equipment